Xenacare Holdings Inc. (XCHO) news stock charts
Xenacare Holdings Inc. (XCHO/XCHO.OB) Investment Summary:
XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. Its clinical products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocysteine levels designed to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the body’s oxygen carrying capacities designed to support digestion. XenaCare’s clinical products also comprise body replenishment products. In addition, the company offers formulations for the lifestyle performance market, which consists of sports line for athletes, including S...XENACARE HOLDINGS INC (XCHO:OTC Bulletin Board Market)
Snapshot of XENACARE HOLDINGS INC (XCHO)
|
OPEN
$0.44
|
PREVIOUS CLOSE
$0.45
|
|
|
DAY HIGH
$0.46
|
DAY LOW
$0.41
|
|
|
52 WEEK HIGH
02/16/10 - $0.55
|
52 WEEK LOW
08/5/09 - $0.01
|
|
|
MARKET CAP
29.6M
|
AVERAGE VOLUME 10 D
174.9K
|
|
|
EPS TTM
$-0.06
|
SHARES OUTSTANDING
65.7M
|
|
|
XCHO Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for XENACARE HOLDINGS INC (XCHO)
Xenacare Holdings Inc. announced that its over-the-counter (OTC) pain reliever, Cobroxin, will be available for purchase in Walgreens by May 1, 2010. Walgreens is considered one of the nation's largest pharmacy chains with 7,162 drugstores located throughout the United States. Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. Cobroxin is currently available as an Advanced Oral Spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as an Advanced Topical Gel for treating joint pain and pain associated with repetitive stress and arthritis. Additional benefits to Cobroxin include: All Natural; Non-Addictive; Non-Narcotic; Non-Opiate; Long Lasting.
XenaCare Holdings Inc. announced that its award winning over-the-counter (OTC) pain reliever, Cobroxin Advanced Topical Gel, is now available at Duane Reade drugstores located throughout metropolitan New York. Duane Reade currently operates 253 stores in Manhattan. Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. Cobroxin is currently available as an Advanced Oral Spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as an Advanced Topical Gel for treating joint pain and pain associated with repetitive stress and arthritis.
XenaCare Holdings Inc. announced that its over-the-counter pain reliever, Cobroxin, is now available at Hannaford and Sweetbay Supermarkets. Cobroxin is the first over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet, and Vicodin. Cobroxin is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis. Additional benefits to Cobroxin include: all natural; non-addictive; non-narcotic; non-opiate; and long lasting.
Xenacare Holdings Inc. financial resources
XCHO Competitors
| Company | Last | Change | |
| No competitor information is available for XCHO. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | XCHO | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | NM | Not Meaningful |
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
|
XCHO |
||
XCHO transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Xenacare Holdings Inc.
XenaCare Holdings Announces Changes to Cobroxin Advertising Campaign and Signing of Professional Athletic Sponsorship
Read article
Cobroxin Now Available at Hannaford and Sweetbay Supermarkets
Read article
Over-the-Counter (OTC) Pain Reliever, Cobroxin, to be Sold in Walgreens
Read article
Over-the-Counter (OTC) Pain Reliever, Cobroxin, to be Sold in Walgreens
Read article
XenaCare Holdings Announces Changes to Cobroxin Advertising Campaign and Signing of Professional Athletic Sponsorship
Read article
Cobroxin Advanced Topical Gel Now Available at Duane Reade
Read article
XenaCare Holdings Announces Upcoming Cobroxin Advertising in the NCAA March Madness Tournament Program
Read article
Cobroxin Now Available at Hannaford and Sweetbay Supermarkets
Read article
XENACARE HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Read article
XenaCare Holdings Announces Agreement to Market its Over-the-Counter Pain Reliever, Cobroxin, in the Official Annual Publication of NASCAR
Read article
XenaCare Holdings Announces Agreement to Market OTC Pain Reliever, Cobroxin, in the National Football League (NFL) Alumni Association Publication
Read article
XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation
Read article
XenaCare Holdings Announces Availability of Cobroxin through the Chain Drug Marketing Association (CDMA)
Read article
XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
Read article
XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
Read article
Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain
Read article
Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever
Read article
XENACARE HOLDINGS, INC. Files SEC form 10-Q/A, Quarterly Report
Read article
Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain
Read article
XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
Read article